All In MedTech

Device Trial Radar · NCT04984590

Early Feasibility Study Using IOPCL MAG to Improve Near Vision in ARMD Subjects

Early Feasibility Study to Evaluate the Safety and Effectiveness of the Intraoperative Pseudophakic Capsular Lens Magnifier for Age-Related Macular Degeneration (IOPCL AMD-MAG) for Secondary Implantation in the Capsular Bag to Improve Near Vision in Subjects With Age-Related Macular Degeneration After Cataract Surgery

Last checked: Nov 20, 2026Latest source record: Jan 31, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

9

Actual

Start

Jan 21, 2022

Primary completion

Mar 20, 2024

Study completion Mar 20, 2024

Sponsor

Lead sponsor
OnPoint Vision IncNot on our public-company list
Sponsor type
Industry
First posted
Jul 30, 2021

More device trials from this sponsor

Design

Study type
Interventional
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This early feasibility study aims to improve near vision in subjects 55 years or older who have a clinical diagnosis of Age-Related Macular Degeneration. Subjects must have previously been implanted with either the Alcon Model SN60WF or Model SA60AT intraocular lens at least 6-months prior to receiving the IOPCL (intraocular pseudophakic capsular lens). Subject will be followed for a period of 12-months.

Conditions

  • Low Vision
  • Age Related Macular Degeneration

Interventions

  • IOPCL AMD MAGDevice

    The IOPCL MAG (intraocular pseudophakic capsular lens magnifier) consists of a 4.5 mm diameter optic. The central 1.8mm of the anterior surface has a power of 10.0 diopters. This IOPCL MAG will be implanted over an Alcon Model SN60WF or SA60AT intraocular lens to improve near vision.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Tilt of the PCIOL and IOPCL MAG ComplexTime frame: 12 Months
  2. IOPCL MAG DecentrationTime frame: 12 Months
  3. Uncorrected Near Visual Acuity at 14cm Change From Baseline (Letters) (≥ 75% Achieving ≥ 10 Letters)Time frame: 12 Months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Harvard Eye Associates

    Laguna Hills, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.